Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis

OBJECTIVES: Recently, a number of studies have explored the possible attenuation of the immune response by disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA). Our study objective was to investigate the presumed attenuated humoral response to vaccination against...

Descripción completa

Detalles Bibliográficos
Autores principales: Schäfer, Arne, Kovacs, Magdolna Szilvia, Eder, Anna, Nigg, Axel, Feuchtenberger, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376125/
https://www.ncbi.nlm.nih.gov/pubmed/35965290
http://dx.doi.org/10.1007/s10067-022-06329-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376125/
https://www.ncbi.nlm.nih.gov/pubmed/35965290
http://dx.doi.org/10.1007/s10067-022-06329-2

Ejemplares similares